High Agreement Between an Ultrasensitive C. difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin EIAs and Cytotoxin Testing.
The Singulex Clarity® C. diff toxins A/B (Clarity) assay is an automated, ultrasensitive immunoassay for the detection of Clostridioides difficile toxins in stool. Here, the performance of the Clarity assay was compared to a multistep algorithm using an EIA for detection of glutamate dehydrogenase (GDH) and toxins A and B arbitrated by a semiquantitative cell cytotoxicity neutralization assay (CCNA). The performance of the assay was evaluated using 211 residual de-identified stool samples tested with a GDH-and-toxin EIA (C. DIFF QUIK CHEK COMPLETE®, Techlab), with GDH-and-toxin discordant samples tested with CCNA. The stool samples were stored at -80oC before tested with the Clarity assay. For samples discordant between Clarity and the standard-of-care algorithm, the samples were tested with polymerase chain reaction (Xpert® C. difficile, Cepheid), and chart review was performed. The testing algorithm resulted in 34 GDH+/toxin+, 53 GDH-/toxin- and 124 GDH+/toxin- samples, of which 39 were CCNA+ and 85 were CCNA-. Clarity had 96.2% negative agreement with GDH-/toxin- samples, 100% positive agreement with GDH+/toxin+ samples, and 95.3% agreement with GDH+/toxin-/CCNA- samples. The Clarity result was invalid for one sample. Clarity agreed with 61.5% of GDH+/toxin-/CCNA+ samples; 90.0% of GDH+/toxin-/CCNA+(high-positive) samples and 31.6% of GDH+/toxin-/CCNA+(low-positive) samples. The Singulex Clarity C. diff toxins A/B assay demonstrated high agreement with a testing algorithm utilizing a GDH-and-toxin EIA and CCNA. This novel automated assay may offer an accurate, standalone solution for C. difficile infection (CDI) diagnostics, and further prospective clinical studies are merited..